MAGISNAT, a pioneer in personalized well-being, is set to captivate audiences with two significant events in Atlanta. On December 13th, the company will host a company presentation press conference at the Georgia State Capitol, followed by an in-depth scientific meeting at Atlanta Tech Park on December 14th. These events underscore MAGISNAT’s unwavering commitment to revolutionizing individual health through the application of omics sciences and groundbreaking approaches to personalized dietary supplementation.
Company Presentation at Georgia State Capitol – December 13th
On December 13th, from 3:00 PM to 4:00 PM, MAGISNAT’s company presentation at the Georgia State Capitol in Atlanta promises to be an engaging and informative event. Matteo Bertelli, Founder and President of MAGISNAT, and other notable speakers, will delve into the latest advancements in personalized well-being and the transformative power of omics sciences in shaping the future of healthcare.
The press conference will feature presentations from a range of esteemed individuals, including:
- Representative from Governor’s Office
- Matteo Bertelli, CEO of MAGISNAT
- Kevin Donato from MAGISNAT
- Eva Alvino, Italian Vice Consul General in Miami
- Nick Masino from the Gwinnett Chamber of Commerce
- Deven Cason from Partnership Gwinnett
- E. Jane Caraway from the Business Development Department of the State of Georgia
- Pietro Chiurazzi, representing both MAGISNAT and the Catholic University of Rome
In-Depth Scientific Meeting at Atlanta Tech Park – December 14th
The highlight of MAGISNAT’s event series is the in-depth scientific meeting at Atlanta Tech Park on December 14th, from 3:00 PM to 6:00 PM. This session will feature presentations from MAGISNAT’s key scientists. Attendees will gain a deeper understanding of the science behind MAGISNAT’s personalized approach to well-being and explore the company’s cutting-edge research in areas such as lipedema treatment and eating disorder prevention.
The scientific meeting will feature in-depth presentations from experts in the field, including:
- Nashlee Young and Robin Bienfait from Atlanta Tech Park
- Bertrand Lapoire from the City of Peachtree Corners
- Andrew Hickey from Partnership Gwinnett
- Matteo Bertelli, CEO of MAGISNAT
- Kevin Donato from MAGISNAT
- Gabriele Bonetti from MAGISNAT
- Maria Chiara Medori from MAGISNAT
- Kristjana Dhuli from MAGISNAT
- Pietro Chiurazzi from MAGISNAT
Unveiling the Power of Omics Sciences for Personalized Well-being
MAGISNAT’s mission is firmly rooted in the belief that personalized well-being is the foundation for optimal health. The company leverages omics sciences, including genomics, metabolomics, and proteomics, to gain a comprehensive understanding of each individual’s unique genetic makeup, lifestyle factors, and dietary needs. This deep insight empowers MAGISNAT to provide tailored solutions that address the specific health requirements of each individual.*
Personalized Dietary Approaches for Enhanced Well-being
MAGISNAT’s Omics Tests provide a personalized roadmap for individuals seeking to optimize their health and well-being. These tests analyze an individual’s genetic predispositions, metabolic profile, and protein expression levels, uncovering valuable insights that guide the selection of the most suitable dietary supplements. This personalized approach ensures that individuals are consuming the nutrients their bodies need to thrive.*
MAGISNAT’s Patents: Pioneering Personalized Well-being
MAGISNAT’s innovative research has led to the development of six patents that are transforming the landscape of personalized well-being. These patents encompass groundbreaking approaches to dietary supplementation, lipedema treatment, oral mucositis prevention, and eating disorder management.
Patent 1: Personalized Dietary Supplementation
Through the application of omics sciences, MAGISNAT has developed a unique “OMICS Machine” that models human molecular pathways. This model allows for the creation of personalized dietary supplements tailored to each individual’s specific genetic and metabolic profile.
Patent 2: Reducing Harmful Cigarette Compounds
MAGISNAT’s innovative filter technology has the potential to significantly reduce the exposure to harmful compounds in cigarette smoke. By functionalizing the filter with small molecules, MAGISNAT has demonstrated a notable decrease in cigarette smoke toxins due to molecular interactions within the functionalized filter and smoke compounds. This innovative approach holds promise for mitigating the harm and toxicity associated with cigarette smoking.
Patent 3: Identifying Genetic Variants Associated with Lipedema
MAGISNAT’s groundbreaking research has identified the first gene associated with lipedema, a chronic fat disorder that disproportionately affects women. This discovery, made in collaboration with the University of Arizona, has shed light on the genetic underpinnings of lipedema and opened up new avenues for treatment and prevention strategies.
Patent 4: Modulating Mast Cells for Lipedema Treatment
MAGISNAT’s research has delved into the role of mast cells in lipedema, identifying their potential contribution to adipose tissue growth and inflammation. By studying the effects of sodium cromoglycate, a compound known to modulate mast cell activity, MAGISNAT has demonstrated a promising approach to reducing lipedema symptoms such as pain and fat deposition.
Patent 5: Targeting Amino Acid Ratios for Eating Disorder Management
MAGISNAT’s research has explored the role of amino acid ratios in appetite regulation, uncovering specific ratios that play a key role in this delicate control process. By studying the metabolic profiles of individuals with eating disorders, MAGISNAT has identified significant differences compared to healthy controls. This knowledge has led to the development of targeted amino acid supplementation aimed at influencing appetite regulation and promoting a healthier relationship with food.
Patent 6: Preventing Oral Mucositis with Lactobacillus Reuteri
MAGISNAT’s research has focused on the potential of Lactobacillus reuteri, a beneficial bacterium naturally present in the oral cavity, to prevent or treat oral mucositis. By developing a patented gel composition that includes Lactobacillus reuteri, MAGISNAT has demonstrated a promising approach to reducing inflammation and competing with pathogenic microorganisms in the oral cavity, offering relief for individuals suffering from oral mucositis.
Join the Well-being Revolution
MAGISNAT cordially invites media representatives, healthcare professionals, and individuals passionate about advancing health and wellness to attend these enlightening events. Discover how MAGISNAT is transforming the healthcare landscape, empowering individuals to take control of their well-being and achieve optimal health through personalized, science-backed approaches.*